| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |